POC(Point-Of-Care) 혈당 검사 시장 규모, 점유율, 성장 분석 : 유형별, 용도별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Point-Of-Care Glucose Testing Market Size, Share, Growth Analysis, By Type (Lancing Devices and Strips, Blood-Glucose Meter), By Application (Type-1 Diabetes, Type-2 Diabetes), By End User, By Region - Industry Forecast 2025-2032
상품코드:1623755
리서치사:SkyQuest Technology Consulting Pvt. Ltd.
발행일:2024년 12월
페이지 정보:영문 184 Pages
라이선스 & 가격 (부가세 별도)
한글목차
POC(Point-Of-Care) 혈당 검사 시장 규모는 2023년 34억 4,000만 달러로 평가되었고, 2024년 35억 8,000만 달러에서 2032년 49억 8,000만 달러로 성장할 것으로 예상되며, 예측 기간(2025-2032년) 동안 4.2%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.
당뇨병 유병률 증가와 편리하고 즉각적인 혈당 모니터링 솔루션에 대한 수요에 힘입어 전 세계 현장 혈당 검사 시장이 크게 성장하고 있습니다. 휴대용 검사 기기를 통해 의료 전문가와 환자는 진료 시점에 혈당 수치를 신속하게 평가할 수 있으며, 더 나은 질병 관리와 환자 예후 개선을 촉진할 수 있습니다. 시장 확대는 기술 발전과 일상적인 혈당 모니터링의 중요성에 대한 인식 증가로 지원되고 있습니다. 그러나 기기 가격 및 검사 정확도 확보와 같은 문제는 주의해야 할 사항입니다. 특히 새로운 바이오센서 기술과 디지털 헬스 플랫폼과의 통합 등 기술 혁신의 기회는 풍부하며, 당뇨병 관리를 강화하고 전 세계 환자들에게 힘을 실어줌으로써 궁극적으로 치료를 간소화하고 의료 비용을 절감할 수 있는 시장으로 발전할 수 있습니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차 데이터와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요의 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
POC(Point-Of-Care) 혈당 검사 시장 규모 : 유형별
시장 개요
천자 기구와 스트립
혈당치 측정기
POC(Point-Of-Care) 혈당 검사 시장 규모 : 용도별
시장 개요
1형 당뇨병
2형 당뇨병
POC(Point-Of-Care) 혈당 검사 시장 규모 : 최종사용자별
시장 개요
병원과 진료소
홈케어 설정
기타
POC(Point-Of-Care) 혈당 검사 시장 규모
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
시장의 최근 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 개요
회사 개요
제품 포트폴리오 분석
부문별 점유율 분석
매출의 전년대비 비교(2022-2024)
주요 기업 개요
Abbott Laboratories(USA)
Roche Holding AG(Switzerland)
Ascensia Diabetes Care Holdings AG(Switzerland)
Dexcom, Inc.(USA)
Medtronic plc(Ireland)
LifeScan, Inc.(USA)
Becton, Dickinson and Company(BD)(USA)
ACON Laboratories, Inc.(USA)
Nova Biomedical Corporation(USA)
ARKRAY, Inc.(Japan)
Trividia Health, Inc.(USA)
PTS Diagnostics(USA)
Nipro Corporation(Japan)
Ypsomed Holding AG(Switzerland)
Sanofi S.A.(France)
EKF Diagnostics Holdings plc(UK)
Prodigy Diabetes Care, LLC(USA)
Bayer AG(Germany)
Danaher Corporation(USA)
Platinum Equity Advisors, LLC(USA)
결론과 권장사항
KSA
영문 목차
영문목차
Point-of-care Glucose Testing Market size was valued at USD 3.44 Billion in 2023 and is poised to grow from USD 3.58 Billion in 2024 to USD 4.98 Billion by 2032, growing at a CAGR of 4.2% during the forecast period (2025-2032).
The global point-of-care glucose testing market is experiencing substantial growth, fueled by the rising prevalence of diabetes and the demand for convenient, immediate glucose monitoring solutions. Portable testing devices enable healthcare professionals and patients to rapidly assess blood sugar levels at the point of care, promoting better disease management and improved patient outcomes. The market's expansion is supported by advancements in technology and heightened awareness of the importance of routine glucose monitoring. However, challenges like device affordability and ensuring test accuracy need attention. Opportunities for innovation abound, particularly with emerging biosensor technologies and integration with digital health platforms, positioning the market to enhance diabetes management and empower patients worldwide, ultimately aiming to streamline care and reduce healthcare costs.
Top-down and bottom-up approaches were used to estimate and validate the size of the Point-Of-Care Glucose Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Point-Of-Care Glucose Testing Market is segmented by type, application, end user and region. Based on type, the market is segmented into lancing devices and strips and blood-glucose meter. Based on application, the market is segmented into type-1 diabetes and type-2 diabetes. Based on end user, the market is segmented into hospitals and clinics, home care settings and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Point-Of-Care Glucose Testing Market
One of the primary catalysts for growth in the point-of-care glucose testing market is the rising prevalence of diabetes worldwide. As reported by the International Diabetes Federation, the number of adults diagnosed with diabetes is projected to soar to 700 million by 2045. This alarming increase highlights the critical need for consistent glucose monitoring to manage the condition effectively. Consequently, the growing population of diabetes patients significantly boosts the demand for point-of-care testing devices, which offer timely and convenient monitoring solutions. This trend underscores the vital role that these testing systems play in improving patient care and health outcomes in diabetes management.
Restraints in the Point-Of-Care Glucose Testing Market
One significant restraint on the Point-of-Care Glucose Testing market is the high cost associated with testing devices and related consumables. This financial barrier can impede market expansion, especially in developing areas where healthcare resources are scarce, and disposable incomes are lower. The elevated prices of these testing devices may deter extensive adoption, particularly within low-income populations and healthcare institutions operating under budget limitations. As a result, the affordability issue poses a challenge to the accessibility of point-of-care glucose testing, thereby affecting its utilization and potential growth in various regions where economic constraints exist.
Market Trends of the Point-Of-Care Glucose Testing Market
The Point-Of-Care Glucose Testing market is increasingly characterized by the integration of testing devices with digital health platforms and electronic health records. This trend, gaining momentum through 2022 and beyond, facilitates seamless data transfer and real-time monitoring of glucose levels, enhancing patient engagement in diabetes management. By empowering individuals with actionable insights and enabling healthcare professionals to access comprehensive patient data, this integration supports informed decision-making and personalized treatment plans. As technology continues to advance, the demand for interconnected health solutions is expected to grow, driving innovations in the Point-Of-Care Glucose Testing sector and improving patient outcomes.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Global Point-Of-Care Glucose Testing Market Size by Type & CAGR (2025-2032)
Market Overview
Lancing Devices and Strips
Blood-Glucose Meter
Global Point-Of-Care Glucose Testing Market Size by Application & CAGR (2025-2032)
Market Overview
Type-1 Diabetes
Type-2 Diabetes
Global Point-Of-Care Glucose Testing Market Size by End User & CAGR (2025-2032)
Market Overview
Hospitals and Clinics
Home Care Settings
Others
Global Point-Of-Care Glucose Testing Market Size & CAGR (2025-2032)
North America (Type, Application, End User)
US
Canada
Europe (Type, Application, End User)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Type, Application, End User)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Type, Application, End User)
Brazil
Rest of Latin America
Middle East & Africa (Type, Application, End User)
